Astrocytoma Drug Market is driven by Rising Incidence
The Astrocytoma Drug Market encompasses innovative therapies designed to treat astrocytoma, a common form of brain tumor originating in star-shaped glial cells. This market features targeted small-molecule inhibitors, monoclonal antibodies, and immunotherapies that offer advantages such as blood–brain barrier penetration, reduced systemic toxicity, and personalized treatment approaches....
0 Comentários 0 Compartilhamentos 89 Visualizações 0 Anterior